58
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma

, , , , , , , , , & show all
Pages 4533-4550 | Published online: 25 Sep 2014

References

  • VenookAPPapandreouCFuruseJde GuevaraLLThe incidence and epidemiology of hepatocellular carcinoma: a global and regional perspectiveOncologist201015Suppl 451321115576
  • YangJDRobertsLREpidemiology and management of hepatocellular carcinomaInfect Dis Clin North Am20102489991920937457
  • YuenMFHonCHuiCKSiuCWLaiCLRecombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinomaJ Clin Gastroenterol20023527227512192207
  • ChuaCWChooSPTargeted therapy in hepatocellular carcinomaInt J Hepatol2011201119
  • Le BuanecHGougeonMLMathianAIFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cellsProc Natl Acad Sci U S A2011108189951900022065791
  • YiTElsonPMitsuhashiMPhosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effectsOncotarget201121155116422201704
  • ShinoharaNAbeTSazawaAInterferon-alpha-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situJpn J Clin Oncol20124211311922131341
  • SingalAKFreemanDHJrAnandBSMeta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinomaAliment Pharmacol Ther20103285185820659285
  • BreitensteinSDimitroulisDPetrowskyHSystematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitisBr J Surg20099697598119672926
  • WangBXRahbarRFishENInterferon: current status and future prospects in cancer therapyJ Interferon Cytokine Res20113154555221323567
  • LesinskiGBRaigETGuenterbergKIFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosisCancer Res2008688351836018922907
  • SatthapornSAloysiusMMRobinsRAEx vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alphaBMC Immunol200893218588665
  • XuanCStewardKKTimmermanJMMorrisonSLTargeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphomaBlood20101152864287120139095
  • BukowskiRErnstoffMSGoreMEPegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II studyJ Clin Oncol2002203841384912228203
  • WangYSYoungsterSGraceMBauschJBordensRWyssDFStructural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implicationsAdv Drug Deliv Rev20025454757012052714
  • GalorAKarpCLChhabraSBarnesSAlfonsoECTopical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison studyBr J Ophthalmol20109455155419493859
  • García-JimenoSEscribanoEQueraltJEstelrichJExternal magnetic field-induced selective biodistribution of magnetoliposomes in miceNanoscale Res Lett2012745222883385
  • SinghRNalwaHSMedical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugsJ Biomed Nanotechnol2011748950321870454
  • SolomonMD’SouzaGGRecent progress in the therapeutic applications of nanotechnologyCurr Opin Pediatr20112321522021412081
  • JingHWangJYangPKeXXiaGChenBMagnetic Fe3O4 nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cellsInt J Nanomedicine20105999100421187919
  • WangCZhangHChenBYinHWangWStudy of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticlesInt J Nanomedicine201161929193521931488
  • KawaguchiEShimokawaKIshiiFPhysicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systemsColloids Surf B Biointerfaces20086213013517988839
  • WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
  • KimMJJangDHLeeYIJungHSLeeHJChoaYHPreparation, characterization, cytotoxicity and drug release behavior of liposome-enveloped paclitaxel/Fe3O4 nanoparticlesJ Nanosci Nanotechnol20111188989321446568
  • CintiCTarantaMNaldiIGrimaldiSNewly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compoundsPloS One2011617132
  • EinatMResnitzkyDKimchiAClose link between reduction of c-myc expression by interferon, and G0/G1 arrestNature19853135976003881681
  • Yamamoto-YamaguchiYOkabe-KadoJKasukabeTHonmaYInduction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cellAnticancer Res2003232537254712894538
  • XuDEricksonSSzepsMInterferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cellsBlood2000964313431811110707
  • AzzimontiBPaganoMMondiniMAltered patterns of the interferon inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation indexHistopathology20044556057215569046
  • MatsuiWHuffCAValaMBarberJSmithBDJonesRJAnti-tumour activity of interferon alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiationBr J Haematol200312125125812694246
  • YangEKorsmeyerSJMolecular thanatopsis: a discourse on the BCL2 family and cell deathBlood1996883864018695785
  • MejíasRPérez-YagüeSGutiérrezLDimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapyBiomaterials2011322938295221277630
  • JahnkeAHirschbergerJFischerCIntra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I studyJ Vet Med A Physiol Pathol Clin Med20075459960618045346
  • DouHDestacheCJMoreheadJRDevelopment of a macrophage-based nanoparticle platform for antiretroviral drug deliveryBlood20061082827283516809617
  • AmendolaVMeneghettiMGranozziGTop-down synthesis of multifunctional iron oxide nanoparticles for macrophage labeling and manipulationJ Mater Chem20112138033813
  • CarvalhoAGonçalvesMCMartinsMBMeixedoDFeioGRelaxivities of magnetoliposomes: the effect of cholesterolMagn Reson Imaging20133161061223333578
  • RudelTCaspase inhibitors in prevention of apoptosisHerz19992423624110412648
  • HockenberyDNuñezGMillimanCSchreiberRDKorsmeyerSJBcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature19903483343362250705
  • OltvaiZNMillimanCLKorsmeyerSJBcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell deathCell1993746096198358790
  • ColletierJPChaizeBWinterhalterMFournierDProtein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayerBMC Biotechnol20022912003642